In an interview with PharmaShots, Dr. Dale Christensen, Ph.D., Director of Clinical Development at TFF Pharmaceuticals shared his views on the preliminary data from the P-I trial of inhalable tacrolimus powder formulation for Lung Transplant & its TFF technologyShots:TFF has developed an inhalable tacrolimus powder formulation that can be delivered directly to the lung via an inhaler bypassing…
